Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France-Reference-Cited by-同舟云学术

Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France

Published:2017-06 Issue:6 Volume:12 Page:963-973
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Guibert Nicolas,Barlesi Fabrice,Descourt Renaud,Léna Hervé,Besse Benjamin,Beau-Faller Michèle,Mosser Jean,Pichon Eric,Merlio Jean-Philippe,Ouafik L'Houcine,Guichard François,Mastroianni Bénédicte,Moreau Lionel,Wdowik Annie,Sabourin Jean-Christophe,Lemoine Antoinette,Missy Pascale,Langlais Alexandra,Moro-Sibilot Denis,Mazières Julien

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT);Barlesi;Lancet,2016

2. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013

3. Cancer. Addiction to oncogenes—the Achilles heal of cancer;Weinstein;Science,2002

4. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers;Shigematsu;J Natl Cancer Inst,2005

5. Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations;Chevrier;Int J Oncol,2014

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies;Critical Reviews in Oncology/Hematology;2024-04

2. EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component;Asian Journal of Surgery;2024-01

3. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGFR;Revue des Maladies Respiratoires Actualités;2023-10

4. Real‐world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi‐center study;Cancer Science;2023-03-12

5. Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer;Journal of Thoracic Disease;2023-02